Skip to main content
Clinical Trials/CTRI/2020/01/022886
CTRI/2020/01/022886
Completed
未知

Vitamin C versus Placebo in Pediatric Septic Shock (VITACiPS)- A Randomised Controlled Trial - VITACiPS

All India Institute of Medical Sciences0 sites218 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
All India Institute of Medical Sciences
Enrollment
218
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
November 30, 2023
Last Updated
2 years ago
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\. Children 2 months to \= 17 years of age admitted to the ICU with a diagnosis of septic shock

Exclusion Criteria

  • 1\. Children with chronic kidney disease.
  • 2\. Children with fulminant myocarditis
  • 3\. Children with dengue shock syndrome
  • 4\. Children on Vitamin C or Thiamine or steroid supplements
  • 5\. Children on anticancer drugs, drugs for autoimmune diseases
  • 6\. Children with G6PD deficiency
  • 7\. Children on iron supplements for iron deficiency anemia (can exaggerate iron absorption, iron overload and tissue damage)
  • 8\. Post\-arrest shock and cardiac dysfunction
  • 9\. Moribund patients in who anticipated survival is \< 24 hrs (adjuvant therapy may not make a difference as they are already in a downward spiral).

Outcomes

Primary Outcomes

Not specified

Similar Trials